NYSE
EW

Edwards Lifesciences Corp

ORTHOPEDIC
LIFE SCIENCES

Prices are adjusted according to historical splits.

Edwards Lifesciences Corp Stock Price

Vitals

Today's Low:
$70.3000
Today's High:
$73.8700
Open Price:
$72.5900
52W Low:
$69.7
52W High:
$131.73
Prev. Close:
$72.5900
Volume:
11861195

Company Statistics

Market Cap.:
$43.470 billion
Book Value:
10.04
Revenue TTM:
$5.364 billion
Operating Margin TTM:
31.8%
Gross Profit TTM:
$3.984 billion
Gross Profit TTM:
$3.984 billion
Profit Margin:
27.2%
Return on Assets TTM:
12.7%
Return on Equity TTM:
24.8%

Company Profile

Edwards Lifesciences Corp had its IPO on 2000-03-27 under the ticker symbol EW.

The company operates in the LIFE SCIENCES sector and ORTHOPEDIC industry. Edwards Lifesciences Corp has a staff strength of 0 employees.

Stock update

Shares of Edwards Lifesciences Corp opened at $72.59 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $70.3 - $73.87, and closed at $70.31.

This is a -3.14% slip from the previous day's closing price.

A total volume of 11,861,195 shares were traded at the close of the day’s session.

In the last one week, shares of Edwards Lifesciences Corp have slipped by -18.24%.

Edwards Lifesciences Corp's Key Ratios

Edwards Lifesciences Corp has a market cap of $43.470 billion, indicating a price to book ratio of 7.22 and a price to sales ratio of 8.1.

In the last 12-months Edwards Lifesciences Corp’s revenue was $5.364 billion with a gross profit of $3.984 billion and an EBITDA of $1.844 billion. The EBITDA ratio measures Edwards Lifesciences Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Edwards Lifesciences Corp’s operating margin was 31.8% while its return on assets stood at 12.7% with a return of equity of 24.8%.

In Q3, Edwards Lifesciences Corp’s quarterly earnings growth was a positive 1.9% while revenue growth was a positive 0.7%.

Edwards Lifesciences Corp’s PE and PEG Ratio

Forward PE
29.15
Trailing PE
29.67
PEG
2.572

Its diluted EPS in the last 12-months stands at $2.37 per share while it has a forward price to earnings multiple of 29.15 and a PEG multiple of 2.572. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Edwards Lifesciences Corp’s profitability.

Edwards Lifesciences Corp stock is trading at a EV to sales ratio of 8.17 and a EV to EBITDA ratio of 22.18. Its price to sales ratio in the trailing 12-months stood at 8.1.

Edwards Lifesciences Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Edwards Lifesciences Corp ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Edwards Lifesciences Corp ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Edwards Lifesciences Corp’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Edwards Lifesciences Corp's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Edwards Lifesciences Corp paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$70.31
52-Week High
$131.73
52-Week Low
$69.7
Analyst Target Price
$95.36

Edwards Lifesciences Corp stock is currently trading at $70.31 per share. It touched a 52-week high of $131.73 and a 52-week low of $131.73. Analysts tracking the stock have a 12-month average target price of $95.36.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Edwards Lifesciences Corp

The stock symbol (also called stock or share ticker) of Edwards Lifesciences Corp is EW

The IPO of Edwards Lifesciences Corp took place on 2000-03-27

Similar Industry Stocks (ORTHOPEDIC)

Last Price
Chg
Chg%
$23.17
0.74
+3.3%
$56.45
-0.42
-0.74%
STERIS plc (STE)
$165.95
-6.92
-4%
Sientra Inc (SIEN)
$0.21
-0.03
-13.59%
Inogen Inc (INGN)
$21.36
-1.82
-7.85%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.

Address

ONE EDWARDS WAY, IRVINE, CA, US